[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3884 Reported in House (RH)]
<DOC>
Union Calendar No. 132
118th CONGRESS
1st Session
H. R. 3884
[Report No. 118-166]
To amend title XI of the Public Health Service Act to reauthorize the
program providing for sickle cell disease and other heritable blood
disorders research, surveillance, prevention, and treatment.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 7, 2023
Mr. Burgess (for himself, Mr. Davis of Illinois, and Mr. Carter of
Georgia) introduced the following bill; which was referred to the
Committee on Energy and Commerce
August 25, 2023
Additional sponsor: Ms. Lee of California
August 25, 2023
Reported with an amendment, committed to the Committee of the Whole
House on the State of the Union, and ordered to be printed
[Strike out all after the enacting clause and insert the part printed
in italic]
[For text of introduced bill, see copy of bill as introduced on June 7,
2023]
_______________________________________________________________________
A BILL
To amend title XI of the Public Health Service Act to reauthorize the
program providing for sickle cell disease and other heritable blood
disorders research, surveillance, prevention, and treatment.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Sickle Cell Disease and Other
Heritable Blood Disorders Research, Surveillance, Prevention, and
Treatment Act of 2023''.
SEC. 2. REAUTHORIZATION OF SICKLE CELL DISEASE AND OTHER HERITABLE
BLOOD DISORDERS RESEARCH, SURVEILLANCE, PREVENTION, AND
TREATMENT.
Section 1106(b) of the Public Health Service Act (42 U.S.C. 300b-
5(b)) is amended--
(1) in paragraph (3)(A), by inserting ``, grant, or
cooperative agreement'' after ``contract''; and
(2) in paragraph (6), by striking ``$4,455,000 for each of
fiscal years 2019 through 2023'' and inserting ``$8,205,000 for
each of fiscal years 2024 through 2028''.
Union Calendar No. 132
118th CONGRESS
1st Session
H. R. 3884
[Report No. 118-166]
_______________________________________________________________________
A BILL
To amend title XI of the Public Health Service Act to reauthorize the
program providing for sickle cell disease and other heritable blood
disorders research, surveillance, prevention, and treatment.
_______________________________________________________________________
August 25, 2023
Reported with an amendment, committed to the Committee of the Whole
House on the State of the Union, and ordered to be printed
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
#3884 | HR Congress #118
Policy Area: Health
Last Action: Placed on the Union Calendar, Calendar No. 132. (8/25/2023)
Bill Text Source: Congress.gov
Summary and Impacts
Original Text